29.4.2011   

PT

Jornal Oficial da União Europeia

C 128/1


Resumo das decisões da União Europeia relativas às autorizações de introdução no mercado dos medicamentos de 1 de Janeiro de 2011 para 28 de Fevereiro de 2011

[Publicado nos termos do artigo 13.o ou do artigo 38.o do Regulamento (CE) n.o 726/2004 do Parlamento Europeu e do Conselho  (1) ]

2011/C 128/01

—   Concessão de uma autorização de introdução no mercado (Artigo 13 do Regulamento (CE) n.o 726/2004 do Parlamento Europeu e do Conselho): Autorizado

Data da decisão

Nome do medicamento

DCI (Denominação Comum Internacional)

Titular da autorização de introdução no mercado

Número de inscrição no Registo Comunitário

Forma farmacêutica

Código ATC (código anatómico-terapêutico-químico)

Data de notificação

6.1.2011

Potactasol

topotecano

Actavis Group PTC ehf.

Reykjavíkurvegi 76-78, 220 Hafnarfjörður, Iceland

EU/1/10/660/001-002

Pó para concentrado para solução para perfusão

L01XX17

10.1.2011

21.1.2011

Docetaxel Teva Pharma

docetaxel

Teva Pharma B.V.

Computerweg 10, DR Utrecht 3542, Nederland

EU/1/10/662/001-002

Concentrado e solvente para solução para perfusão

L01CD02

26.1.2011

21.1.2011

Iasibon

Ácido ibandrónico

Pharmathen S.A.

6 Dervenakion, 15351 Pallini Attiki, Ελλάδα

EU/1/10/659/001-010

Comprimido revestido por película

Concentrado para solução para perfusão

M05BA06

25.1.2011

27.1.2011

Fluenz

vacina contra a gripe (viva atenuada, nasal)

MedImmune, LLC

Lagelandseweg 78, 6545 CG Nijmegen, Nederland

EU/1/10/661/001-002

Suspensão para pulverização nasal

J07BB03

1.2.2011

18.2.2011

Entacapone Teva

entacapona

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/10/665/001-004

Comprimido revestido por película

N04BX02

22.2.2011

28.2.2011

Daliresp

roflumilaste

Nycomed GmbH

Byk-Gulden-Str. 2, D-78467 Konstanz, Deutschland

EU/1/11/668/001-003

Comprimido revestido por película

R03DX07

2.3.2011

28.2.2011

Esbriet

Pirfenidona

InterMune Europe Ltd

Wellesley House, Duke of Wellington Avenue, Royal Arsenal, London SE18 6SS, United Kingdom

EU/1/11/667/001-003

Cápsula

L04AX05

2.3.2011

28.2.2011

Lamivudine / Zidovudine Teva

Lamivudina/Zidovudina

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/10/663/001-002

Comprimido revestido por película

J05AR01

2.3.2011

28.2.2011

Libertek

roflumilaste

Nycomed GmbH

Byk-Gulden-Str. 2, D-78467 Konstanz, Deutschland

EU/1/11/666/001-003

Comprimido revestido por película

R03DX07

2.3.2011

28.2.2011

Xiapex

clostridium histolyticum colagenase

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ United Kingdom

EU/1/11/671/001

Pó e solvente para solução injectável

M09AB02

2.3.2011


—   Alteração de uma autorização de introdução no mercado (Artigo 13.o do Regulamento (CE) n.o 726/2004 do Parlamento Europeu e do Conselho): Autorizado

Data da decisão

Nome do medicamento

Titular da autorização de introdução no mercado

Número de inscrição no Registo Comunitário

Data de notificação

6.1.2011

Invirase

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/96/026/001-002

10.1.2011

6.1.2011

Irbesartan HCT Winthrop

SANOFI PHARMA BRISTOL MYERS SQUIBB SNC

174 avenue de France, F- 75013 Paris, France

EU/1/06/377/001-028

11.1.2011

6.1.2011

Irbesartan Winthrop

SANOFI PHARMA BRISTOL MYERS SQUIBB SNC

174 avenue de France, F- 75013 Paris, France

EU/1/06/376/001-033

11.1.2011

6.1.2011

Lucentis

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/06/374/001

11.1.2011

6.1.2011

Rapamune

Wyeth Europa Limited

Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom

EU/1/01/171/001

EU/1/01/171/007-010

EU/1/01/171/013-014

11.1.2011

6.1.2011

Resolor

Movetis NV

Veedijk 58, B-2300 Turnhout, België

EU/1/09/581/001-008

11.1.2011

6.1.2011

Tepadina

ADIENNE S.r.l.

via Broseta, 64/B, 24128 Bergamo, Italia

EU/1/10/622/001-002

11.1.2011

6.1.2011

Yttriga

Eckert & Ziegler Nuclitec GmbH

Gieselweg 1, Braunschweig 38110, Deutschland

EU/1/05/322/001

10.1.2011

11.1.2011

IntronA

Schering Plough Europe

Rue de Stalle, 73, 1180 Bruxelles, Belgique - Stallestraat, 73 - 1180 Brussel, België

EU/1/99/127/011-039

EU/1/99/127/041-044

18.1.2011

11.1.2011

Pantoloc Control

Nycomed GmbH

Byk-Gulden-Str. 2, D-78467 Konstanz, Deutschland

EU/1/09/519/001-004

13.1.2011

11.1.2011

Rapiscan

Gilead Sciences International Limited

Cambridge CB21 6GT United Kingdom

EU/1/10/643/001

13.1.2010

13.1.2011

Clopidogrel Winthrop

Sanofi-Aventis

174, avenue de France, F-75013 Paris, France

EU/1/08/465/001-020

17.1.2011

13.1.2011

Copalia

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/06/372/037-039

17.1.2010

13.1.2011

INOmax

INO Therapeutics AB

SE-181 81 Lidingö, Sverige

EU/1/01/194/001-002

18.1.2011

13.1.2011

Iscover

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/98/070/001a-001b

EU/1/98/070/002a-002b

EU/1/98/070/003a-003b

EU/1/98/070/004a-004b

EU/1/98/070/005a-005b

EU/1/98/070/006a-006b

EU/1/98/070/007a-007b

EU/1/98/070/008-010

EU/1/98/070/011a-011b

EU/1/98/070/012

17.1.2011

13.1.2011

Nimvastid

KRKA, d.d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/09/525/001-050

17.1.2011

13.1.2011

Plavix

Sanofi Pharma Bristol-Myers Squibb SNC

174 avenue de France - 75013 Paris, France

EU/1/98/069/001a-001b

EU/1/98/069/002a-002b

EU/1/98/069/003a-003b

EU/1/98/069/004a-004b

EU/1/98/069/005a-005b

EU/1/98/069/006a-006b

EU/1/98/069/007a-007b

EU/1/98/069/008-010

EU/1/98/069/011a-011b

EU/1/98/069/012

17.1.2011

17.1.2011

Cancidas

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/01/196/001

EU/1/01/196/003

19.1.2011

17.1.2011

Kuvan

Merck KGaA

Frankfurter Straße 250, 64293 Darmstadt, Deutschland

EU/1/08/481/001-003

19.1.2011

17.1.2011

Nevanac

Alcon Laboratories (UK) Ltd.

Boundary Way, Hemel Hempstead, Herts HP2 7UD, United Kingdom

EU/1/07/433/001

19.1.2011

21.1.2011

Abilify

Otsuka Pharmaceutical Europe Ltd

Hunton House, Highbridge Business Park, Oxford Road, Uxbridge, Middlesex UB8 1HU, United Kingdom

EU/1/04/276/001-020

EU/1/04/276/024-036

25.1.2011

21.1.2011

Adenuric

Menarini International Operations Luxembourg S.A.

1, Avenue de la Gare, L-1611 Luxembourg, Luxembourg

EU/1/08/447/001-004

25.1.2011

21.1.2011

Arzerra

Glaxo Group Ltd

Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom

EU/1/10/625/001-002

26.1.2011

21.1.2011

Cubicin

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/05/328/001-004

25.1.2011

21.1.2011

Enbrel

Wyeth Europa Limited

Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom

EU/1/99/126/001-021

25.1.2011

21.1.2011

Humira

Abbott Laboratories

Abbott House, Vanwall Business Park, Vanwall Road, SL6 4XE Maidenhead, Berks, United Kingdom

EU/1/03/256/001-010

25.1.2011

21.1.2011

INOmax

INO Therapeutics AB

SE-181 81 Lidingö, Sverige

EU/1/01/194/001-002

25.1.2011

21.1.2011

Karvea

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/97/049/001-039

26.1.2011

21.1.2011

Kuvan

Merck KGaA

Frankfurter Straße 250, 64293 Darmstadt, Deutschland

EU/1/08/481/001-003

25.1.2011

21.1.2011

Mixtard

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/02/231/001-023

EU/1/02/231/036-037

25.1.2011

21.1.2011

Multaq

Sanofi-Aventis

174, avenue de France, F-75013 Paris, France

EU/1/09/591/001-004

25.1.2011

21.1.2011

Olazax Disperzi

Glenmark Pharmaceuticals s.r.o.

City Tower, Hvězdova 1716/2b, 140 78 Praha 4, Česká republika

EU/1/09/592/001-005

25.1.2011

21.1.2011

Pandemrix

GlaxoSmithKline Biologicals S.A.

rue de l'Institut 89, Rixensart, B-1330 Belgique

EU/1/08/452/001

26.1.2011

21.1.2011

Pradaxa

Boehringer Ingelheim International GmbH

Binger Strasse 173, D-55216 Ingelheim am Rhein, Deutschland

EU/1/08/442/001-008

25.1.2011

21.1.2011

Rapamune

Wyeth Europa Limited

Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom

EU/1/01/171/001

EU/1/01/171/007-010

EU/1/01/171/013-014

26.1.2011

21.1.2011

Rasilez

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/07/405/001-040

25.1.2011

21.1.2011

Revatio

Pfizer Limited

Sandwich, Kent, CT13 9NJ, United Kingdom

EU/1/05/318/002

25.1.2011

21.1.2011

Revlimid

Celgene Europe Limited

Riverside House, Riverside Walk, Windsor, Berkshire SL4 1NA, United Kingdom

EU/1/07/391/001-004

26.1.2011

21.1.2011

RotaTeq

Sanofi Pasteur MSD, SNC

8, rue Jonas Salk, Lyon 69007, France

EU/1/06/348/001-002

26.1.2011

21.1.2011

Sprimeo

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/07/407/001-020

26.1.2011

21.1.2011

Temomedac

medac Gesellschaft für klinische Spezialpräparate mbH

Fehlandtstrasse 3, D-20354 Hamburg - Deutschland

EU/1/09/605/001-012

26.1.2011

21.1.2011

Thymanax

Servier (Ireland) Industries Limited

Gorey Road, Arklow, Co. Wicklow, Ireland

EU/1/08/498/001-008

25.1.2011

21.1.2011

Valdoxan

Les Laboratoires Servier

22, rue Garnier, 92200 Neuilly-sur-Seine, France

EU/1/08/499/001-008

26.1.2011

21.1.2011

Yentreve

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/04/280/001-008

25.1.2011

24.1.2011

Apidra

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main, Deutschland

EU/1/04/285/001-036

27.1.2011

24.1.2011

Ceplene

EpiCept GmbH

Goethestrasse 4, D-80336 München, Deutschland

EU/1/08/477/001

27.1.2011

24.1.2011

Dafiro

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/06/371/001-039

27.1.2011

24.1.2011

Eucreas

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/07/425/001-018

27.1.2011

24.1.2011

Galvus

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/07/414/001-010

U/1/07/414/018

27.1.2011

24.1.2011

Isentress

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/07/436/001-002

27.1.2011

24.1.2011

Jalra

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/08/485/001-011

27.1.2011

24.1.2011

Lantus

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main, Deutschland

EU/1/00/134/001-037

27.1.2011

24.1.2011

NutropinAq

Ipsen Pharma

65, quai Georges Gorse, 92100 Boulogne-Billancourt, France

EU/1/00/164/003-005

27.1.2011

24.1.2011

Olanzapine Glenmark

Glenmark Generics (Europe) Limited

Laxmi House, 2-B Draycott Avenue, Kenton, Harrow, Middlesex HA3 OBU, United Kingdom

EU/1/09/587/001-017

27.1.2011

24.1.2011

Olanzapine Glenmark Europe

Glenmark Generics (Europe) Limited

Laxmi House, 2-B Draycott Avenue, Kenton, Harrow, Middlesex HA3 OBU, United Kingdom

EU/1/09/588/001-012

27.1.2011

24.1.2011

Optisulin

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main, Deutschland

EU/1/00/133/001-032

27.1.2011

24.1.2011

Pelzont

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/460/009-011

EU/1/08/460/013-014

26.1.2011

24.1.2011

Rotarix

GlaxoSmithKline Biologicals S.A.

rue de l'Institut 89, Rixensart, B-1330 Belgique

EU/1/05/330/001-011

27.1.2011

24.1.2011

SonoVue

Bracco International B.V.

Strawinskylaan 3051, 1077 ZX Amsterdam, Nederland

EU/1/01/177/002

27.1.2011

24.1.2011

Synflorix

GlaxoSmithKline Biologicals S.A.

rue de l'Institut 89, 1330 Rixensart, Belgique

EU/1/09/508/001-010

27.1.2011

24.1.2011

Torisel

Wyeth Europa Ltd

Huntercombe Lane South, Taplow, Maidenhead, Berkshire SL6 0PH, United Kingdom

EU/1/07/424/001

27.1.2011

24.1.2011

Tredaptive

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/459/009-011

EU/1/08/459/013-014

26.1.2011

24.1.2011

Trevaclyn

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/458/009-011

EU/1/08/458/013-014

26.1.2011

24.1.2011

Vistide

Gilead Sciences International Limited

Cambridge, CB21 6GT, United Kingdom

EU/1/97/037/001

27.1.2011

24.1.2011

Xarelto

Bayer Schering Pharma AG

13342 Berlin, Deutschland

EU/1/08/472/001-010

27.1.2011

24.1.2011

Xiliarx

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/08/486/001-011

27.1.2011

26.1.2011

Naglazyme

BioMarin Europe Ltd

164 Shaftesbury Avenue, London WC2H 8HL, United Kingdom

EU/1/05/324/001-002

27.1.2011

27.1.2011

Adrovance

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/06/364/001-009

1.2.2011

27.1.2011

Alimta

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/04/290/001-002

1.2.2011

27.1.2011

Cymbalta

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/04/296/001-009

31.1.2011

27.1.2011

Herceptin

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/00/145/001

1.2.2011

27.1.2011

Icandra

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/08/484/001-018

1.2.2011

27.1.2011

Menveo

Novartis Vaccines and Diagnostics S.r.l.

Via Fiorentina, 1, 53100 Siena, Italia

EU/1/10/614/001

31.1.2011

27.1.2011

Nonafact

Sanquin

Plesmanlaan 125, Amsterdam 1066 CX, Nederland

EU/1/01/186/001-002

1.2.2011

27.1.2011

Orgalutran

N.V. Organon

P.O. Box 20, Kloosterstraat 6, 5340 BH Oss, Nederland

EU/1/00/130/001-002

31.1.2011

27.1.2011

Ranexa

Menarini International Operations Luxembourg S.A.

1, Avenue de la Gare, L-1611 Luxembourg, Luxembourg

EU/1/08/462/001-012

1.2.2011

27.1.2011

Rasilez HCT

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/08/491/001-080

1.2.2011

27.1.2011

Regranex

Janssen-Cilag International NV

Turnhoutseweg, 30 - 2340 Beerse - België

EU/1/99/101/001

31.1.2011

27.1.2011

Remicade

Centocor B.V.

Einsteinweg 101, 2333 CB Leiden, Nederland

EU/1/99/116/001-005

1.2.2011

27.1.2011

Ribavirin Mylan

Three Rivers Global Pharma Limited

20-22 Bedford Row, London WC1R4JS, United Kingdom

EU/1/10/634/001-004

23.2.2011

27.1.2011

RotaTeq

Sanofi Pasteur MSD, SNC

8, rue Jonas Salk, Lyon 69007, France

EU/1/06/348/001-002

1.2.2011

27.1.2011

Sebivo

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/07/388/001-003

1.2.2011

27.1.2011

Simponi

Centocor B.V.

Einsteinweg 101, 2333 CB Leiden, Nederland

EU/1/09/546/001-004

31.1.2011

27.1.2011

Xeristar

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/04/297/001-008

1.2.2011

27.1.2011

Zomarist

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/08/483/001-018

1.2.2011

1.2.2011

Ariclaim

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/04/283/008-012

3.2.2011

1.2.2011

Emend

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/03/262/001-008

3.2.2011

1.2.2011

Exforge

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/06/370/001-039

3.2.2011

1.2.2011

Fosavance

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/05/310/001-009

3.2.2011

1.2.2011

Imprida

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/06/373/001-039

3.2.2011

1.2.2011

INCRELEX

Ipsen Pharma

65, quai Georges Gorse, 92100 Boulogne-Billancourt, France

EU/1/07/402/001

3.2.2011

1.2.2011

Insulin Human Winthrop

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main, Deutschland

EU/1/06/368/001-168

3.2.2011

1.2.2011

Insuman

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main, Deutschland

EU/1/97/030/028-195

3.2.2011

1.2.2011

Irbesartan Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/576/001-039

3.2.2011

1.2.2011

Nivestim

Hospira UK Limited

Queensway, Royal Leamington Spa, Warwickshire CV31 3RW, United Kingdom

EU/1/10/631/001-009

3.2.2011

1.2.2011

Orfadin

Swedish Orphan Biovitrum International AB

SE-112 76 Stockholm, Sweden

EU/1/04/303/001-003

3.2.2011

1.2.2011

Riprazo

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/07/409/001-020

3.2.2011

1.2.2011

Votrient

Glaxo Group Limited

Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom

EU/1/10/628/001-004

3.2.2011

2.2.2011

Nplate

Amgen Europe B.V.

Minervum 7061, 4817 ZK Breda, Nederland

EU/1/08/497/001-008

4.2.2011

2.2.2011

Prevenar

Wyeth-Lederle Vaccines S.A.

Pleainlaan 17 Boulevard de la Plaine, 1050 Brussels - Bruxelles, Belgium

EU/1/00/167/001-008

4.2.2011

2.2.2011

Prolia

Amgen Europe B.V.

Minervum 7061, NL-4817 ZK Breda, Nederland

EU/1/10/618/001-004

4.2.2011

2.2.2011

Replagal

Shire Human Genetic Therapies AB

Svärdvägen 11D, 182 33 Danderyd, Sverige

EU/1/01/189/001-006

4.2.2011

2.2.2011

Vantavo

Merck Sharp & Dohme Ltd.

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/09/572/001-009

4.2.2011

8.2.2011

Biopoin

CT Arzneimittel GmbH

Lengeder Straße 42a, D-13407 Berlin, Deutschland

EU/1/09/565/001-028

10.2.2011

8.2.2011

Temodal

Schering Plough Europe

Rue de Stalle, 73, 1180 Bruxelles, Belgique - Stallestraat, 73 - 1180 Brussel, België

EU/1/98/096/001-025

14.2.2011

9.2.2011

Cimzia

UCB Pharma SA.

Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef, 60, Brussel 1070, België

EU/1/09/544/001-002

11.2.2011

9.2.2011

Karvezide

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/98/085/001-034

11.2.2011

9.2.2011

Olazax

Glenmark Pharmaceuticals s.r.o.

City Tower, Hvězdova 1716/2b, 140 78 Praha 4, Česká republika

EU/1/09/597/001-005

11.2.2011

9.2.2011

Peyona

CHIESI FARMACEUTICI SpA

Via Palermo 26/A, I-43100 Parma, ITALIA

EU/1/09/528/001-002

11.2.2011

9.2.2011

Tesavel

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/07/435/001-018

11.2.2011

9.2.2011

Xelevia

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/07/382/001-018

11.2.2011

11.2.2011

Aprovel

Sanofi Pharma Bristol-Myers Squibb SNC

174 avenue de France - 75013 Paris, France

EU/1/97/046/001-039

15.2.2011

11.2.2011

Azarga

Alcon Laboratories (UK) Ltd.

Pentagon Park, Boundary Way, Hemel Hempstead, Herts HP2 7UD, United Kingdom

EU/1/08/482/001-002

15.2.2011

11.2.2011

Brinavess

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/10/645/001-002

15.2.2011

11.2.2011

Clopidogrel Krka

KRKA, d. d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/09/556/001-011

15.2.2011

11.2.2011

CoAprovel

Sanofi Pharma Bristol-Myers Squibb SNC

174 avenue de France - 75013 Paris, France

EU/1/98/086/001-034

15.2.2011

11.2.2011

Crixivan

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/96/024/001-005

EU/1/96/024/008

EU/1/96/024/010

15.2.2011

11.2.2011

Eporatio

ratiopharm GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/09/573/001-028

15.2.2011

11.2.2011

Januvia

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/07/383/001-018

15.2.2011

11.2.2011

Rilonacept Regeneron

Regeneron UK Limited

40 Bank Street, E14 5DS London, United Kingdom

EU/1/09/582/001

15.2.2011

11.2.2011

Zutectra

Biotest Pharma GmbH

Landsteinerstr.5, 63303 Dreieich, Deutschland

EU/1/09/600/001

15.2.2011

11.2.2011

Zyllt

KRKA, d.d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/09/553/001-010

15.2.2011

18.2.2011

Actrapid

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/02/230/001-007

EU/1/02/230/016-017

22.2.2011

18.2.2011

Elaprase

Shire Human Genetic Therapies AB

Svärdvägen 11D, 182 33 Danderyd, Sverige

EU/1/06/365/001-003

22.2.2011

18.2.2011

Keppra

UCB Pharma SA.

Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef, 60, Brussel 1070, België

EU/1/00/146/001-032

22.2.2011

18.2.2011

Mimpara

Amgen Europe B.V.

Minervum 7061, NL-4817 ZK Breda, Nederland

EU/1/04/292/001-012

22.2.2011

18.2.2011

Optaflu

Novartis Vaccines and Diagnostics GmbH

Emil-von-Behring-Strasse 76, D-35041 Marburg, Deutschland

EU/1/07/394/001-009

22.2.2011

18.2.2011

Renagel

Genzyme Europe B.V.

Gooimeer 10, NL-1411 DD Naarden, Nederland

EU/1/99/123/005-013

22.2.2011

21.2.2011

Arzerra

Glaxo Group Ltd

Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom

EU/1/10/625/001-003

25.2.2011

21.2.2011

Baraclude

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/06/343/001-007

28.2.2011

21.2.2011

Cervarix

GlaxoSmithKline Biologicals S.A.

rue de l'Institut 89, 1330 Rixensart, Belgique

EU/1/07/419/001-012

25.2.2011

21.2.2011

Cialis

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/02/237/001-009

23.2.2011

21.2.2011

Clopidogrel Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/540/001-016

24.2.2011

21.2.2011

Competact

Takeda Global Research and Development Centre (Europe) Ltd

61 Aldwych, London WC2B 4AE, United Kingdom

EU/1/06/354/001-011

23.2.2011

21.2.2011

Conbriza

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/09/511/001-005

23.2.2011

21.2.2011

Dukoral

Crucell Sweden AB

SE-105 21 Stockholm, Sweden

EU/1/03/263/001-003

1.3.2011

21.2.2011

Dynastat

Pfizer Ltd

Ramsgate Road, Sandwich, Kent CT 13 9NJ, United Kingdom

EU/1/02/209/001-008

23.2.2011

21.2.2011

Efficib

Merck Sharp & Dohme Ltd.

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/457/001-016

24.2.2011

21.2.2011

Enbrel

Wyeth Europa Limited

Huntercombe Lane South, Taplow, Maidenhead, Berkshire, SL6 0PH, United Kingdom

EU/1/99/126/001-021

25.2.2011

21.2.2011

Firazyr

Jerini AG

Invalidenstr. 130, D-10115 Berlin, Deutschland

EU/1/08/461/001-002

24.2.2011

21.2.2011

Glivec

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/01/198/001-013

28.2.2011

21.2.2011

Humira

Abbott Laboratories Ltd

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE, United Kingdom

EU/1/03/256/001-010

23.2.2011

21.2.2011

Insulatard

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/02/233/005-007

25.2.2011

21.2.2011

Intanza

Sanofi Pasteur MSD SNC

8, rue Jonas Salk, Lyon 69007, France

EU/1/08/505/001-006

23.2.2011

21.2.2011

Ivemend

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/07/437/001-004

24.2.2011

21.2.2011

Janumet

Merck Sharp & Dohme Ltd.

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/455/001-016

24.2.2011

21.2.2011

Kineret

Swedish Orphan Biovitrum AB (publ)

SE-112 76, Stockholm, Sverige

EU/1/02/203/001-004

25.2.2011

21.2.2011

Levemir

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/04/278/001-003

28.2.2011

21.2.2011

Myozyme

Genzyme Europe B.V.

Gooimeer 10, NL-1411 DD Naarden, Nederland

EU/1/06/333/001-003

28.2.2011

21.2.2011

Neupro

Schwarz Pharma Ltd

Shannon, Industrial Estate, Co.Clare, Ireland

EU/1/05/331/001-055

25.2.2011

21.2.2011

Pritor

Bayer Schering Pharma AG

13342 Berlin, Deutschland

EU/1/98/089/001-022

25.0.2011

21.2.2011

PritorPlus

Bayer Schering Pharma AG

13342 Berlin, Deutschland

EU/1/02/215/001-021

28.2.2011

21.2.2011

Protaphane

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/02/234/005-007

25.2.2011

21.2.2011

Protopic

Astellas Pharma Europe B.V.

Elisabethhof 19, NL-2353 EW Leiderdorp, Nederland

EU/1/02/201/001-006

28.2.2011

21.2.2011

Qutenza

Astellas Pharma Europe B.V.

Elisabethhof 19, 2353 EW Leiderdorp, Nederland

EU/1/09/524/001-002

25.2.2011

21.2.2011

Ranexa

Menarini International Operations Luxembourg S.A.

1, Avenue de la Gare, L-1611 Luxembourg, Luxembourg

EU/1/08/462/001-012

25.2.2011

21.2.2011

Rasilez

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/07/405/001-040

25.2.2011

21.2.2011

Rasilez HCT

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/08/491/001-080

25.2.2011

21.2.2011

Remicade

Janssen Biologics B.V.

Einsteinweg 101, 2333 CB Leiden, Nederland

EU/1/99/116/001-005

25.2.2011

21.2.2011

Ribavirin Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/509/001-004

24.2.2011

21.2.2011

Ribavirin Teva Pharma BV

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/527/001-016

24.2.2011

21.2.2011

Riprazo

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/07/409/001-020

28.2.2011

21.2.2011

Ristaben

Merck Sharp & Dohme Ltd.

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/10/621/001-018

24.2.2011

21.2.2011

Ristfor

Merck Sharp & Dohme Ltd.

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/10/620/001-016

24.2.2011

21.2.2011

Simponi

Janssen Biologics B.V.

Einsteinweg 101, CB Leiden 2333, Nederland

EU/1/09/546/001-004

23.2.2011

21.2.2011

Sprimeo

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/07/407/001-020

28.3.2011

21.2.2011

Stocrin

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/99/111/001-005

EU/1/99/111/008-011

25.2.2011

21.2.2011

Tamiflu

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/02/222/001-004

23.2.2011

21.2.2011

Tysabri

Elan Pharma International Ltd.

Monksland, Athlone, County Westmeath, Ireland

EU/1/06/346/001

23.2.2011

21.2.2011

Velmetia

Merck Sharp & Dohme Ltd.

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/456/001-016

24.2.2011

21.2.2011

Ventavis

Bayer Schering Pharma AG

Müllerstrasse 170-178, D - 13342 Berlin, Deutschland

EU/1/03/255/001-008

23.2.2011

21.2.2011

Volibris

Glaxo Group Ltd

Greenford, Middlesex UB6 0NN, United Kingdom

EU/1/08/451/001-004

2.3.2011

21.2.2011

Zylagren

KRKA, d. d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/09/558/001-010

28.2.2011

21.2.2011

Zyprexa

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/96/022/016-017

23.2.2011

28.2.2011

Altargo

Glaxo Group Limited

Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom

EU/1/07/390/001-004

4.3.2011

28.2.2011

Aranesp

Amgen Europe B.V.

Minervum 7061, NL-4817 ZK Breda, Nederland

EU/1/01/185/001-022

EU/1/01/185/031-111

4.3.2011

28.2.2011

Arixtra

Glaxo Group Ltd.

Greenford Road, Greenford, Middlesex UB6 0NN, United Kingdom

EU/1/02/206/001-035

2.3.2011

28.2.2011

Avastin

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/04/300/001-002

4.3.2011

28.2.2011

Baraclude

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/06/343/001-007

3.3.2011

28.2.2011

Clopidogrel Qualimed

Qualimed

117, Allée des Parcs, 69 800 Saint Priest, France

EU/1/09/557/001-010

4.3.2011

28.2.2011

Clopidogrel TAD

TAD Pharma GmbH

Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Deutschland

EU/1/09/555/001-009

4.3.2011

28.2.2011

Fabrazyme

Genzyme Europe B.V.

Gooimeer 10, NL-1411 DD Naarden, Nederland

EU/1/01/188/001-006

4.3.2011

28.2.2011

Firazyr

Jerini AG

Invalidenstr. 130, D-10115 Berlin, Deutschland

EU/1/08/461/001-002

4.3.2011

28.2.2011

IDflu

Sanofi Pasteur SA

2, avenue Pont Pasteur, F-69007 Lyon, France

EU/1/08/507/001-006

3.3.2011

28.2.2011

Ilaris

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/09/564/001-002

4.3.2011

28.2.2011

Invanz

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/02/216/001-002

3.3.2011

28.2.2011

Kaletra

Abbott Laboratories

Abbott House, Vanwall Business Park, Vanwall Road, SL6 4XE Maidenhead, Berks, United Kingdom

EU/1/01/172/001-008

4.3.2011

28.2.2011

Kinzalkomb

Bayer Schering Pharma AG

D-13342 Berlin, Deutschland

EU/1/02/214/001-015

2.3.2011

28.2.2011

Kinzalmono

Bayer Schering Pharma AG

D-13342 Berlin, Deutschland

EU/1/98/091/001-014

2.3.2011

28.2.2011

Micardis

Boehringer Ingelheim International GmbH

Binger Strasse 173- D - 55216 Ingelheim am Rhein, Deutschland

EU/1/98/090/001-020

2.3.2011

28.2.2011

MicardisPlus

Boehringer Ingelheim International GmbH

Binger Strasse 173- D - 55216 Ingelheim am Rhein, Deutschland

EU/1/02/213/001-023

3.3.2011

28.2.2011

NovoMix

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/00/142/004-005

EU/1/00/142/009-025

3.3.2011

28.2.2011

Omnitrope

Sandoz GmbH

Biochemiestrasse 10, Kundl 6250, Österreich

EU/1/06/332/001-009

2.3.2011

28.2.2011

Onglyza

Bristol Myers Squibb/AstraZeneca EEIG

Bristol Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH, United Kingdom

EU/1/09/545/011-015

3.3.2011

28.2.2011

Onglyza

Bristol Myers Squibb/AstraZeneca EEIG

Bristol Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH, United Kingdom

EU/1/09/545/001-010

3.3.2011

28.2.2011

Osigraft

Howmedica International S. de R.L.

Division of Stryker Corporation, Raheen Industrial Estate, Raheen, Limerick, Ireland

EU/1/01/179/001

4.3.2011

28.2.2011

Osseor

Les Laboratoires Servier

22, rue Garnier, 92200 Neuilly-sur-Seine, France

EU/1/04/287/001-006

4.3.2011

28.2.2011

PegIntron

Schering Plough Europe

Rue de Stalle, 73, 1180 Bruxelles, Belgique - Stallestraat, 73 - 1180 Brussel, België

EU/1/00/131/001-050

3.3.2011

28.2.2011

PREZISTA

Janssen-Cilag International NV

Turnhoutseweg, 30 - 2340 Beerse - België

EU/1/06/380/001-005

4.3.2011

28.2.2011

ProQuad

Sanofi Pasteur MSD, SNC

8, rue Jonas Salk, 69007 Lyon, France

EU/1/05/323/001-013

2.3.2011

28.2.2011

Protelos

Les Laboratoires Servier

22, rue Garnier, 92200 Neuilly-sur-Seine, France

EU/1/04/288/001-006

4.3.2011

28.2.2011

Quadramet

CIS bio international

Boite Postale 32 - F-91192 Gif-sur-Yvette - France

EU/1/97/057/001

4.4.2011

28.2.2011

RotaTeq

Sanofi Pasteur MSD, SNC

8, rue Jonas Salk, Lyon 69007, France

EU/1/06/348/001-002

3.3.2011

28.2.2011

Siklos

ADDMEDICA

101, rue Saint Lazare, Paris 75009, France

EU/1/07/397/001-004

3.3.2011

28.2.2011

Tracleer

Actelion Registration Ltd

BSI Building 13th Floor, 389 Chiswick High Road, London W4 4AL, United Kingdom

EU/1/02/220/001-006

3.3.2011

28.2.2011

Vedrop

Orphan Europe SARL

Immeuble Le Wilson - 70 Avenue du Général de Gaulle - F 92 800 Puteaux - France

EU/1/09/533/001-003

3.3.2011

28.2.2011

Ytracis

CIS bio international

Boite Postale 32 - F-91192 Gif-sur-Yvette Cedex- France

EU/1/03/250/001

4.3.2011


—   Retirada de uma autorização de introdução no mercado (Artigo 13.o do Regulamento (CE) n.o 726/2004 do Parlamento Europeu e do Conselho)

Data da decisão

Nome do medicamento

Titular da autorização de introdução no mercado

Número de inscrição no Registo Comunitário

Data de notificação

6.1.2011

Thelin

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/06/353/001-005

11.1.2011

1.2.2011

Clopidogrel 1A Pharma

Acino Pharma GmbH

Am Windfeld 35, 83714 Miesbach, Deutschland

EU/1/09/542/001-007

3.2.2011


—   Concessão de uma autorização de introdução no mercado(Artigo 38.o do Regulamento (CE) n.o 726/2004 do Parlamento Europeu e do Conselho  (2) ): Autorizado

Data da decisão

Nome do medicamento

DCI (Denominação Comum Internacional)

Titular da autorização de introdução no mercado

Número de inscrição no Registo Comunitário

Forma farmacêutica

Código ATC (código anatómico-terapêutico-químico)

Data de notificação

27.1.2011

Hiprabovis IBR Marker Live

Estirpe CEDDEL do Herpesvírus Bovino tipo 1 (BoHV-1) ,vivo, gE<sup>-</sup> tk<sup>-</sup> duplamente deletado

Laboratorios Hipra, S.A.

Avda. La Selva, 135, 17170- Amer (Girona), España

EU/2/10/114/001-002

Liofilizado para suspensão

QI02AD01

1.2.2011

11.2.2011

Comfortis

spinosad

Eli Lilly and Company Ltd

Priestley Road, Basingstoke, Hampshire RG24 9NL, United Kingdom

EU/2/10/115/001-010

Comprimido para mastigar

QP53BX03

15.2.2011

18.2.2011

Activyl

indoxacarb

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/10/118/001-014

Solução para unção punctiforme

QP53AX27

22.2.2011

18.2.2011

Cimalgex

Cimicoxib

Vétoquinol SA

Magny-Vernois - 70200 LURE - France

EU/2/10/119/001-012

Comprimido

QM01AH93

24.2.2011

18.2.2011

Purevax Rabies

Vírus canarypox recombinante da raiva (vCP65)

MERIAL

29 avenue Tony Garnier, 69007 LYON, France

EU/2/10/117/001-002

Suspensão injectável

QI06AX

22.2.2011

21.2.2011

Melosus

Meloxicam

CP-Pharma Handelsgesellschaft mbH

Ostlandring 13, D-31303 Burgdorf, Deutschland

EU/2/10/116/001-004

Suspensão oral

QM01AC06

24.2.2011


—   Alteração de uma autorização de introdução no mercado (Artigo 38.o do Regulamento (CE) n.o 726/2004 do Parlamento Europeu e do Conselho): Autorizado

Data da decisão

Nome do medicamento

Titular da autorização de introdução no mercado

Número de inscrição no Registo Comunitário

Data de notificação

6.1.2011

Econor

Novartis Animal Health Austria GmbH

Biochemiestrasse 10, 6250 Kundl, Österreich

EU/2/98/010/004-006

EU/2/98/010/017-018

EU/2/98/010/021-025

11.1.2011

13.1.2011

Duvaxyn WNV

Fort Dodge Animal Health Ltd

Flanders Road, Hedge End, Southampton SO30 4QH, United Kingdom

EU/2/08/086/001-003

18.1.2011

13.1.2011

Palladia

Pfizer Ltd

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/2/09/100/001-003

17.1.2011

17.1.2011

Zolvix

Novartis Healthcare A/S

Lyngbyvej 172, DK-2100 Copenhagen, Denmark

EU/2/09/101/001-010

19.1.2011

21.1.2011

Dicural

Fort Dodge Animal Health Holland

C.J. van Houtenlaan 36, 1381 CP Weesp, Nederland

EU/2/97/003/001-018

25.1.2011

21.1.2011

Zulvac 8 Ovis

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/2/09/104/001-002

26.1.2011

24.1.2011

Poulvac FluFend H5N3 RG

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ United Kingdom

EU/2/06/060/001-002

27.1.2011

24.1.2011

Rheumocam

Chanelle Pharmaceuticals Manufacturing Limited

Loughrea, Co. Galway, IRELAND

EU/2/07/078/001-010

26.1.2011

27.1.2011

Ingelvac CircoFLEX

Boehringer Ingelheim Vetmedica GmbH

55216 Ingelheim am Rhein, Deutschland

EU/2/07/079/001-004

1.2.2011

27.1.2011

Meloxidyl

CEVA SANTE ANIMALE

10 avenue de la Ballastière, 33500 Libourne, France

EU/2/06/070/005-007

1.2.2011

11.2.2011

SevoFlo

Abbott Laboratories Limited

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE, UNITED KINGDOM

EU/2/02/035/007

15.2.2011


—   Suspensão de uma autorização de introdução no mercado (Artigo 45.o do Regulamento (CE) n.o 726/2004 do Parlamento Europeu e do Conselho)

Data da decisão

Nome do medicamento

Titular da autorização de introdução no mercado

Número de inscrição no Registo Comunitário

Data de notificação

24.1.2011

Acticam

Ecuphar NV

Legeweg 157-I, B-8020 Oostkamp, Belgïe

EU/2/08/088/001-003

26.1.2011

Os interessados podem solicitar o acesso ao relatório público dos medicamentos em questão e das decisões correspondentes junto de:

The European Medicines Agency

7, Westferry Circus, Canary Wharf

UK - LONDON E14 4H


(1)  JO L 136 de 30.4.04, p. 1.

(2)  JO L 136 de 30.4.04, p. 1.